OTCMKTS:SHJBF Shanghai Junshi Biosciences (SHJBF) Stock Price, News & Analysis C$1.97 0.00 (0.00%) As of 01/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Shanghai Junshi Biosciences Stock (OTCMKTS:SHJBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SHJBF alerts:Sign Up Key Stats Today's RangeC$1.97▼C$1.9750-Day RangeC$1.24▼C$1.9752-Week RangeC$1.24▼C$1.50VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewShanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.Read More… Receive SHJBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Junshi Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address SHJBF Stock News HeadlinesJunshi partners LEO Pharma for toripalimab distribution in EuropeJanuary 22, 2025 | msn.comShanghai Junshi Biosciences Partners with LEO Pharma for European ExpansionJanuary 20, 2025 | tipranks.comIs this the pin that pops the bubble? CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.January 30, 2025 | Porter & Company (Ad)Shanghai Junshi’s Toripalimab Gains TGA Approval for NPC TreatmentJanuary 17, 2025 | tipranks.comShanghai Junshi Biosciences Sees Revenue Growth Amid Reduced Losses in 2024January 17, 2025 | tipranks.comShanghai Junshi Biosciences Receives Regular Approval for COVID-19 DrugJanuary 10, 2025 | tipranks.comShanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy PipelineJanuary 8, 2025 | tipranks.comJunshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma TreatmentJanuary 6, 2025 | tipranks.comSee More Headlines SHJBF Stock Analysis - Frequently Asked Questions How have SHJBF shares performed this year? Shanghai Junshi Biosciences' stock was trading at C$1.24 at the start of the year. Since then, SHJBF stock has increased by 58.9% and is now trading at C$1.97. View the best growth stocks for 2025 here. How do I buy shares of Shanghai Junshi Biosciences? Shares of SHJBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:SHJBF CUSIPN/A CIKN/A Webwww.junshipharma.com Phone86 21 6105 8800FaxN/AEmployees2,568Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (OTCMKTS:SHJBF) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Junshi Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
